NEW YORK & PARIS–(BUSINESS WIRE)–OpenGate Capital (“OpenGate”), a global private equity firm, completed the sale of ScioTeq, a global leader in ruggedized displaysNEW YORK & PARIS–(BUSINESS WIRE)–OpenGate Capital (“OpenGate”), a global private equity firm, completed the sale of ScioTeq, a global leader in ruggedized displays

OpenGate Capital Completes ScioTeq Sale to Tikehau Capital

2025/12/18 15:16
3 min read
For feedback or concerns regarding this content, please contact us at [email protected]

NEW YORK & PARIS–(BUSINESS WIRE)–OpenGate Capital (“OpenGate”), a global private equity firm, completed the sale of ScioTeq, a global leader in ruggedized displays for the aviation and defense industries, to the aerospace and defense fund of global alternative asset manager Tikehau Capital (ISIN code: FR0013230612; Ticker: TKO.FP). OpenGate will maintain a meaningful minority position and will continue to support the company’s next phase of growth.

ScioTeq has a 40-year heritage of designing and manufacturing advanced visualization and computing solutions for the aviation, defense and air traffic control markets. With sales, engineering and manufacturing locations across the world, the company specializes in rugged, high-performance display systems and mission-critical electronics that support situational awareness in the most demanding environments. Utilized by governments and industry leaders worldwide, ScioTeq delivers technology that is engineered for precision, reliability and long-term support.

“This transaction marks a significant milestone for all parties, underscoring the strong market positions and ongoing development that ScioTeq anticipates,” stated Rob Gibbs, CEO of the ScioTeq Group. “Our collaboration with Tikehau Capital allows ScioTeq to access new markets and further expand its product portfolio by leveraging the industry knowledge and connections of Tikehau. With OpenGate remaining as a partner, the company will continue to benefit from valuable expertise and consistent support as it enters this continued phase of growth.”

OpenGate acquired ScioTeq from TransDigm Group Inc. (NYSE: TDG) in 2021 through a corporate carve-out. Under OpenGate’s ownership and with support from its Operations Team, ScioTeq executed a series of strategic growth initiatives, including:

  • Completed the carve-out and establishment of Treality as an independent operating entity
  • Enhanced ScioTeq’s leadership team with the addition of a CEO and Group Sales Director
  • Expanded the global sales organization to accelerate growth in new geographies
  • Advanced MicroLED and Mini LED display technologies for next-generation military applications

“Under our ownership, ScioTeq has undergone a meaningful transformation,” said Andrew Nikou, Founder and Managing Partner at OpenGate Capital. “Together with the company’s leadership, OpenGate strengthened ScioTeq’s capabilities, expanded its global reach and advanced key technologies. This transaction reflects that progress, and with Tikehau Capital’s sector expertise, ScioTeq is well positioned for continued growth. We are pleased to remain a partner in its next chapter.”

About OpenGate

OpenGate is a global private equity firm specializing in the acquisition and operation of businesses to create new value through operational improvements, innovation and growth. Headquartered in both New York and Paris, OpenGate has been building and transforming businesses since 2005. OpenGate’s professionals possess the critical skills needed to acquire, transition, operate, build and scale successful businesses. To date, OpenGate has executed more than 40 platform acquisitions across North America and Europe. To learn more about OpenGate, please visit www.opengatecapital.com.

About Tikehau Capital

Tikehau Capital is a global alternative asset management group with €51.1 billion of assets under management (as of 30 September 2025). Tikehau Capital has developed a wide range of expertise across four asset classes (credit, real assets, private equity and capital markets strategies) as well as multi-asset and special opportunities strategies. Tikehau Capital is a founder-led team with a differentiated business model, a strong balance sheet, proprietary global deal flow and a track record of backing high quality companies and executives. To learn more about Tikehau, please visit www.tikehaucapital.com.

Contacts

For More Information, Please Contact:

OpenGate Media Contact:


Profile Advisors
Email: [email protected]

OpenGate Contact:


Joshua Adams
Partner

Email: [email protected]

Market Opportunity
Toko Token Logo
Toko Token Price(TKO)
$0.05455
$0.05455$0.05455
-4.44%
USD
Toko Token (TKO) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Unprecedented US Military Operation Shakes Middle East Security

Unprecedented US Military Operation Shakes Middle East Security

The post Unprecedented US Military Operation Shakes Middle East Security appeared on BitcoinEthereumNews.com. Trump Kharg Island Airstrike: Unprecedented US Military
Share
BitcoinEthereumNews2026/03/14 07:25
Michael Saylor fires back former UK Prime Minister says Bitcoin is a ponzi scheme

Michael Saylor fires back former UK Prime Minister says Bitcoin is a ponzi scheme

The post Michael Saylor fires back former UK Prime Minister says Bitcoin is a ponzi scheme appeared on BitcoinEthereumNews.com. Michael Saylor has responded sharply
Share
BitcoinEthereumNews2026/03/14 07:22
Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

The post Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves appeared on BitcoinEthereumNews.com. The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee, America’s Health Insurance Plans said Wednesday, Sept. 17, 2025. In this photo is a free flu and Covid-19 vaccine shots available sign, CVS, Queens, New York. (Photo by: Lindsey Nicholson/Universal Images Group via Getty Images) UCG/Universal Images Group via Getty Images The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee. The announcement by America’s Health Insurance Plans (AHIP), which includes CVS Health’s Aetna, Humana, Cigna, Centene and an array of Blue Cross and Blue Shield plans as members, comes ahead of the first meeting of the reconstituted Advisory Committee on Immunization Practices, which now has new members chosen by U.S. Health and Human Services Secretary Robert F. Kennedy Jr., a vaccine critic. “Health plans are committed to maintaining and ensuring affordable access to vaccines,” AHIP said in a statement Wednesday. “Health plan coverage decisions for immunizations are grounded in each plan’s ongoing, rigorous review of scientific and clinical evidence, and continual evaluation of multiple sources of data.” The move by AHIP is good news for millions of Americans at a time of year when they flock to drugstores, pharmacies, physician’s offices and outpatient clinics to get their seasonal flu and Covid shots. Kennedy’s changes to U.S. vaccine policy have created confusion across the country over whether certain vaccines long covered by insurance would continue to be. AHIP has now provided some clarity for millions of Americans. “Health plans will continue to cover all ACIP-recommended immunizations that were recommended as of September 1, 2025, including updated formulations of the COVID-19 and influenza vaccines, with no cost-sharing…
Share
BitcoinEthereumNews2025/09/18 03:11